These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5488528)

  • 1. [Clinical picture and treatment of human fascioliasis. II. Chloxyle therapy of human fascioliasis in early and chronic stages of infection].
    Alekseeva MI; Karzin VV; Karnaukhov VK; Ozeretskovskaia NN; Plotnikov NN
    Med Parazitol (Mosk); 1970; 39(4):409-13. PubMed ID: 5488528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of human fascioliasis with chloxyle (hexachloroparaxylene)].
    Plotnikov NN; Karnaukov VK; Zal'nova NS; Alekseeva MI; Borisov IA; Stromskaia TF
    Med Parazitol (Mosk); 1965; 34(6):725-9. PubMed ID: 5876192
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical picture and treatment of fascioliasis in children and adolescents].
    Plotnikov NN; Karnaukhov VK
    Vopr Okhr Materin Det; 1972 May; 17(5):40-4. PubMed ID: 5029750
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of hepatic fascioliasis treated with Cloxyl].
    Belchiţă A; Dăncescu P; Dudu S; Lăzărescu M; Rafael-Stefănescu G; Tiţeica M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):377-81. PubMed ID: 30156
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of hexachlorparaxylol in fascioliasis].
    Trebukhin MV
    Veterinariia; 1971 Aug; 9():68-9. PubMed ID: 5140682
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.
    Talaie H; Emami H; Yadegarinia D; Nava-Ocampo AA; Massoud J; Azmoudeh M; Mas-Coma S
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):777-82. PubMed ID: 15566392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine fascioliasis: laboratory model for the detection of fasciolicidal activity of chemical compounds.
    Hayes TJ; Bailer J; Mitrovic M
    J Parasitol; 1973 Apr; 59(2):314-8. PubMed ID: 4696579
    [No Abstract]   [Full Text] [Related]  

  • 8. Triclabendazole in the treatment of human fascioliasis: a community-based study.
    el-Morshedy H; Farghaly A; Sharaf S; Abou-Basha L; Barakat R
    East Mediterr Health J; 1999 Sep; 5(5):888-94. PubMed ID: 10983527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of fascioliasis with hexachloroparaxylol combined with antibiotics].
    Khashimov DM; Kamardinov KhK
    Sov Med; 1975 Jun; (6):142-3. PubMed ID: 1162460
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of fascioliasis hepatica with bithionol].
    Grados O; Berrocal LA
    Rev Inst Med Trop Sao Paulo; 1977; 19(6):425-7. PubMed ID: 613437
    [No Abstract]   [Full Text] [Related]  

  • 11. Human fascioliasis: a case of hyperinfection and an update for clinicians.
    Arauco R; Zetola NM; Calderon F; Seas C
    Foodborne Pathog Dis; 2007; 4(3):305-12. PubMed ID: 17883314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug control of cattle fascioliasis in the Steinfurt area. II. Results of the 3-year treatment program].
    Hörchner F; Hennings R; Verspohl F; Averbeck W; Boch J
    Berl Munch Tierarztl Wochenschr; 1970 Jan; 83(2):21-6. PubMed ID: 5534820
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the effectiveness of a series of chemotherapeutic preparations on white rats with fasciolae (Fasciola hepatica L., 1758) implanted under the skin of the back].
    Gusel'nikova LM
    Med Parazitol (Mosk); 1971; 40(2):185-8. PubMed ID: 5568405
    [No Abstract]   [Full Text] [Related]  

  • 14. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human fascioliasis in South America].
    Gorokhov VV; Sergiev VP; Uspenskiĭ AV; Romanenko NA; Vil'iavisensio A; Molchanov IA
    Med Parazitol (Mosk); 2005; (1):55-8. PubMed ID: 15801226
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam.
    Hien TT; Truong NT; Minh NH; Dat HD; Dung NT; Hue NT; Dung TK; Tuan PQ; Campbell JI; Farrar JJ; Day JN
    Am J Trop Med Hyg; 2008 Mar; 78(3):388-92. PubMed ID: 18337331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eight cases of fascioliasis: clinical and microbiological features.
    Dauchy FA; Vincendeau P; Lifermann F
    Med Mal Infect; 2006 Jan; 36(1):42-6. PubMed ID: 16309872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of human fascioliasis with triclabendazole].
    Caminal Montero L; Fernández Fernández C; de Quirós JF; Parra F
    Rev Clin Esp; 1999 May; 199(5):333-5. PubMed ID: 10396163
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of human fascioliasis with triclabendazole: good news.
    Curtale F
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):508. PubMed ID: 18346770
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatic fascioliasis resistant to bithionol treatment but responsive to triclabendazole].
    Medrano F; de Tomás E; Barba MA; Alamillo A; Ferreras P
    Enferm Infecc Microbiol Clin; 1999; 17(7):371-2. PubMed ID: 10535200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.